BioMarin Pharmaceutical(BMRN) - 2024 Q2 - Earnings Call Transcript

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Results Conference Call August 5, 2024 5:30 PM ET Company Participants Traci McCarty - Head of Investor Relations Alexander Hardy - President and Chief Executive Officer Hank Fuchs - President, Worldwide Research & Development Brian Mueller - Executive Vice President, Chief Financial Officer Cristin Hubbard - Executive Vice President, Chief Commercial Officer Conference Call Participants Phil Nadeau - TD Cowen Salveen Richter - Goldman Sachs Ellie Merle - U ...